Hyaluronic Acid Fillers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Hyaluronic Acid Fillers Pipeline Market Report Overview

Hyaluronic Acid (HA) is a glycosaminoglycan disaccharide, which exists naturally in the body. Approximately 50% of total HA is found in the skin, and it is produced by dermal fibroblasts, endothelial cells, synovial cells, adventitial cells, smooth muscle cells, and oocytes. Injections of HA are used for reducing wrinkles in the face and for soft tissue augmentation. One unit refers to one mL of filler.

The hyaluronic acid fillers pipeline market research report provides comprehensive information about the Hyaluronic acid fillers pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Key Segments ·       Biphasic Hyaluronic Acid Fillers
Key Territories ·       The US

·       Europe

·       China

·       Australia

·       India

Key Regulatory Paths ·       510(k)

·       PMA

·       CE

·       NMPA

·       TGA

Leading Companies ·       Allergan Aesthetics

·       Almirall Ltd

·       BioPlus Co Ltd

·       BMG Pharma SpA

·       Bmi Korea Co Ltd

·       CellPraxis

·       Collplant Biotechnologies Ltd

·       Fillmed Laboratoires

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Hyaluronic Acid Fillers Pipeline Market by Segments

The key segment in the hyaluronic acid fillers market is biphasic hyaluronic acid fillers. Biphasic HA fillers consist of two or more substances with different chemical compositions. Biphasic HA fillers are more easily customized to obtain the appropriate particle size to suit the anatomical area being treated. One unit refers to one mL of filler.

Hyaluronic Acid Fillers Pipeline Market Segmentation by Territories

Some of the key territories in the hyaluronic acid fillers market are the US, Europe, China, Australia, and India among others. As of June 2023, Europe had the highest number of pipeline products.

Hyaluronic Acid Fillers Pipeline Market Analysis by Territories, 2023 (%)

Hyaluronic Acid Fillers Pipeline Market Analysis by Territories, 2023 (%)

For more territory insights into the Hyaluronic acid fillers pipeline market, download a free report sample

Hyaluronic Acid Fillers Pipeline Market Segmentation by Regulatory Paths

Some of the key regulatory paths in the Hyaluronic acid fillers pipeline market are 510(k), PMA, CE, NMPA, and TGA among others. As of June 2023, CE was the most followed pathway for pipeline products.

Hyaluronic Acid Fillers Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Hyaluronic Acid Fillers Pipeline Market Analysis by Regulatory Paths, 2023 (%)

For more regulatory path insights into the Hyaluronic acid fillers pipeline market, download a free report sample

Hyaluronic Acid Fillers Pipeline Market – Competitive Landscape

Some of the key companies in the hyaluronic acid fillers pipeline market are Allergan Aesthetics, Almirall Ltd, BioPlus Co Ltd, BMG Pharma SpA, Bmi Korea Co Ltd, CellPraxis, Collplant Biotechnologies Ltd, and Fillmed Laboratories among others.

Almirall Ltd: Almirall Ltd (Almirall), a subsidiary of Almirall SA, is a biopharmaceutical company that develops healthcare solutions for dermatology indications. The company offers product portfolio includes Actikerall cutaneous solution, kanamycin plus cutaneous solution, balenum dry skin, and itch relief cream, balneum cream, balneum dry skin and itch relief lotion, balneum plus bath oil, and other products. Almirall is headquartered in Uxbridge, Middlesex, the UK.

Leading Hyaluronic Acid Fillers Companies, 2023

Leading Hyaluronic Acid Fillers Companies, 2023

For more company insights into the Hyaluronic acid fillers pipeline market, download a free report sample

Segments Covered in the Report

Hyaluronic Acid Fillers Pipeline Market Segments Outlook

  • Biphasic hyaluronic acid fillers

Hyaluronic Acid Fillers Pipeline Market Territories Outlook

  • The US
  • Europe
  • China
  • Australia
  • India

Hyaluronic Acid Fillers Pipeline Market Regulatory Paths Outlook

  • 510(k)
  • PMA
  • CE
  • NMPA
  • TGA

Scope

This report provides:

  • Extensive coverage of the hyaluronic acid fillers under development.
  • Details of major pipeline products which include product description, licensing and collaboration details, and other developmental activities.
  • Reviews of the major players involved in the development of hyaluronic acid fillers and lists of all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage.
  • Key clinical trial data of ongoing trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of Hyaluronic acid fillers under development.
  • Develop market-entry and market expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date.

AbbVie Inc
Allergan Aesthetics
Almirall Ltd
BioPlus Co Ltd
BMG Pharma SpA
Bmi Korea Co Ltd
CellPraxis
Collplant Biotechnologies Ltd
Fillmed Laboratoires
Genzyme Corp
Hallura Ltd
Hugel Inc
Jinwoo Bio Co Ltd
Laboratoires Vivacy SAS
LG Chem Ltd
LifeSprout Inc
Medytox Inc
Merz North America Inc
Mesoestetic Pharma Group SL
Oligo Medic Inc
Q-Med AB
RepliCel Life Sciences Inc
Shanghai Haohai Biological Technology Co Ltd
Shin Poong Pharm Co Ltd
Silk Medical Aesthetics Inc
Sinclair Pharma Ltd
Teoxane SA
Tissueform Inc

Table of Contents

  • 1 Table of Contents

    • 1.1 List of Tables
    • 1.2 List of Figures

  • 2 Introduction

    • 2.1 Hyaluronic Acid Fillers Overview

  • 3 Products under Development

    • 3.1 Hyaluronic Acid Fillers – Pipeline Products by Stage of Development
    • 3.2 Hyaluronic Acid Fillers – Pipeline Products by Segment
    • 3.3 Hyaluronic Acid Fillers – Pipeline Products by Territory
    • 3.4 Hyaluronic Acid Fillers – Pipeline Products by Regulatory Path
    • 3.5 Hyaluronic Acid Fillers – Pipeline Products by Estimated Approval Date
    • 3.6 Hyaluronic Acid Fillers – Ongoing Clinical Trials

  • 4 Hyaluronic Acid Fillers – Pipeline Products under Development by Companies

    • 4.1 Hyaluronic Acid Fillers Companies – Pipeline Products by Stage of Development
    • 4.2 Hyaluronic Acid Fillers – Pipeline Products by Stage of Development

  • 5 Hyaluronic Acid Fillers Companies and Product Overview

    • 5.1 AbbVie Inc Company Overview

      • 5.1.1 AbbVie Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.2 Allergan Aesthetics Company Overview

      • 5.2.1 Allergan Aesthetics Pipeline Products & Ongoing Clinical Trials Overview

    • 5.3 Almirall Ltd Company Overview

      • 5.3.1 Almirall Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.4 BioPlus Co Ltd Company Overview

      • 5.4.1 BioPlus Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.5 BMG Pharma SpA Company Overview

      • 5.5.1 BMG Pharma SpA Pipeline Products & Ongoing Clinical Trials Overview

    • 5.6 Bmi Korea Co Ltd Company Overview

      • 5.6.1 Bmi Korea Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.7 CellPraxis Company Overview

      • 5.7.1 CellPraxis Pipeline Products & Ongoing Clinical Trials Overview

    • 5.8 Collplant Biotechnologies Ltd Company Overview

      • 5.8.1 Collplant Biotechnologies Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.9 Fillmed Laboratoires Company Overview

      • 5.9.1 Fillmed Laboratoires Pipeline Products & Ongoing Clinical Trials Overview

    • 5.10 Genzyme Corp Company Overview

      • 5.10.1 Genzyme Corp Pipeline Products & Ongoing Clinical Trials Overview

    • 5.11 Hallura Ltd Company Overview

      • 5.11.1 Hallura Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.12 Hugel Inc Company Overview

      • 5.12.1 Hugel Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.13 Jinwoo Bio Co Ltd Company Overview

      • 5.13.1 Jinwoo Bio Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.14 Laboratoires Vivacy SAS Company Overview

      • 5.14.1 Laboratoires Vivacy SAS Pipeline Products & Ongoing Clinical Trials Overview

    • 5.15 LG Chem Ltd Company Overview

      • 5.15.1 LG Chem Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.16 LifeSprout Inc Company Overview

      • 5.16.1 LifeSprout Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.17 Medytox Inc Company Overview

      • 5.17.1 Medytox Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.18 Merz North America Inc Company Overview

      • 5.18.1 Merz North America Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.19 Mesoestetic Pharma Group SL Company Overview

      • 5.19.1 Mesoestetic Pharma Group SL Pipeline Products & Ongoing Clinical Trials Overview

    • 5.20 Oligo Medic Inc Company Overview

      • 5.20.1 Oligo Medic Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.21 Q-Med AB Company Overview

      • 5.21.1 Q-Med AB Pipeline Products & Ongoing Clinical Trials Overview

    • 5.22 RepliCel Life Sciences Inc Company Overview

      • 5.22.1 RepliCel Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.23 Shanghai Haohai Biological Technology Co Ltd Company Overview

      • 5.23.1 Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.24 Shin Poong Pharm Co Ltd Company Overview

      • 5.24.1 Shin Poong Pharm Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.25 Silk Medical Aesthetics Inc Company Overview

      • 5.25.1 Silk Medical Aesthetics Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.26 Sinclair Pharma Ltd Company Overview

      • 5.26.1 Sinclair Pharma Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.27 Teoxane SA Company Overview

      • 5.27.1 Teoxane SA Pipeline Products & Ongoing Clinical Trials Overview

    • 5.28 Tissueform Inc Company Overview

      • 5.28.1 Tissueform Inc Pipeline Products & Ongoing Clinical Trials Overview

  • 6 Appendix

    • 6.1 Methodology
    • 6.2 About GlobalData
    • 6.3 Contact Us
    • 6.4 Disclaimer

Frequently asked questions

Hyaluronic Acid Fillers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies thematic reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Hyaluronic Acid Fillers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Medical Devices
Intuitive Surgical Inc - Company Profile
$295 | April 2023
Medical Devices
Hologic Inc - Company Profile
$295 | April 2023
Medical Devices
Becton Dickinson and Co - Company Profile
$295 | April 2023
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Hyaluronic Acid Fillers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Hyaluronic Acid Fillers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.